Cardiff Oncology, Inc. Common Stock (NASDAQ: CRDF) last traded at $0.880, down 3.15% on the session. The quote above updates while this page is open; the figures below are drawn from Cardiff Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cardiff Oncology, Inc. Common Stock trades on NASDAQ under the ticker CRDF. Its market capitalisation is $68.47 million.
Valuation measures for Cardiff Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $68.47M |
|---|---|
| Enterprise value | $70.07M |
| Price / sales | 134.78 |
| Price / book | 2.58 |
| Beta | 2.16 |
Trailing-twelve-month figures tagged in Cardiff Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $508.0K |
|---|---|
| Net income (TTM) | -$40.05M |
| EPS (TTM) | -$0.600 |
| Operating margin | -8320.08% |
| Return on equity | -150.95% |
| Cash | $9.20M |
Range and volume for CRDF over the past 52 weeks.
| 52-week high | $3.31 |
|---|---|
| 52-week low | $0.760 |
| Volume | 631.0K |
| Average volume | 1.47M |
| Previous close | $0.909 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.